 |
Image courtesy of commons.wikimedia.org |
Transvaginal mesh
is a medical device that is surgically implanted to female patients suffering
from Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP).
SUI occurs when there is a urine leakage as a result of pelvic muscles that are
no longer able to support the urethra and bladder. POP mainly affects women
after menopause, childbirth, and hysterectomy.
Thousands of women have received implants, but many of them
suffered from the product’s side effects. On July 2011, the Food and Drug
Administration (FDA) started to investigate the products and issued a public
safety warning.